Clinical manifestations of varicella-zoster virus infection

Dermatologic Clinics

Volumn 20, Issue 2, 2002, Pages 267-282

  Chen, T Minsue ^a   George, Saira ^a   Woodruff, Christy A ^a   Hsu, Sylvia ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; CHICKENPOX VACCINE; FAMCICLOVIR; FOSCARNET; STEROID; VALACICLOVIR; ANTIVIRUS AGENT;

BACTERIAL INFECTION; CHICKENPOX; CLINICAL FEATURE; CLINICAL TRIAL; DISEASE COURSE; FEVER; HEPATITIS; HERPES ZOSTER; HUMAN; IMMUNE DEFICIENCY; IMMUNE STATUS; NEUROLOGIC DISEASE; PNEUMONIA; POSTHERPETIC NEURALGIA; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; REVIEW; SKIN INFECTION; SUPERINFECTION; THROMBOCYTOPENIA; VARICELLA ZOSTER VIRUS; VIRUS INFECTION; DECISION TREE;

ANTIVIRAL AGENTS; CHICKENPOX; CHICKENPOX VACCINE; DECISION TREES; HERPES ZOSTER; HERPESVIRUS 3, HUMAN; HUMAN; HUMANS;

EID: 0035986493     PISSN: 07338635     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0733-8635(01)00012-2     Document Type: Review

References (142)

1. Varicella zoster virus
2. Varicella and herpes zoster: Changing concepts of the natural history, control, and importance of a not-so-benign virus
3. Varicella and herpes zoster: A perspective and overview
4. Complications of varicella requiring hospitalization in previously healthy children
5. Epidemiology of primary varicella and herpes zoster hospitalizations: The pre-varicella vaccine era
6. Varicella: Complications and costs
7. Population-based studies of varicella complications
8. Varicella: Clinical manifestations, epidemiology and health impact in children
9. Modification of chickenpox in family contacts by administration of gamma globulin
10. Herpes viridae: Definition, provisional nomenclature and taxonomy
11. Transmission of chickenpox in a school setting prior to the observed exanthem
12. Airborne transmission of chickenpox in a hospital
13. Detection of varicella-zoster virus DNA in the oropharynx and blood of patients with varicella
14. Detection of varicella-zoster virus DNA in air samples from hospital rooms
15. Varicella-zoster virus
16. Acyclovir treatment of varicella in otherwise healthy children
17. Early immune response in healthy and immunocompromised subjects with primary varicella-zoster virus infection
18. Tropism of varicella-zoster virus for human CD4+ and CD8+ T lymphocytes and epidermal cells in SCID-hu mice
19. Variation on a theme by Fenner: The pathogenesis of chickenpox
20. Detection of varicella-zoster virus DNA in blood of children with varicella
21. Viral replication and immunologic responses in children naturally infected with varicella-zoster virus and in varicella vaccine recipients
22. Detection of varicella-zoster virus nucleic acid in neurons of normal human thoracic ganglia
23. Detection of varicella-zoster viral DNA in human trigeminal and thoracic ganglia
24. Recent advances in varicella-zoster virus infection
25. Selective decline in cellular immune response to varicella-zoster in the elderly
26. Age-related differences in cell-mediated immunity to varicella-zoster virus among children and adults immunized with live attenuated varicella vaccine
27. Viremia caused by varicella-zoster virus: Association with malignant progressive varicella
28. Varicella causes skin pits and keloids: More reasons for the varicella vaccine
29. Photolocalized varicella
30. Immunization, abrasion, and sunburn as localizing factors in chicken pox
31. Age-specific risks of varicella complications
32. Determination of immunity to varicella-zoster virus by means of an intradermal skin test
33. Varicella in children with cancer: Seventy-seven cases
34. Children hospitalized for varicella: A prevaccine review
35. Varicellazoster virus infections in children infected with human immunodeficiency virus
36. Clinical manifestations of varicella-zoster virus infections in human immunodeficiency virus-infected children
37. Varicella in patients infected with the human immunodeficiency virus
38. Intrauterine viral infections
39. Intrauterine infection with varicella-zoster virus after maternal varicella infection
40. Outcome after maternal varicella infection in the first 20 weeks of pregnancy
41. Varicella-zoster virus infections in pregnancy
42. Consequences of varicella and herpes zoster in pregnancy: Prospective study of 1739 cases
43. Virus detection in the fetal tissue of a premature delivery with congenital varicella syndrome: A case report
44. Bacterial complications of primary varicella in children
45. The Immunization Monitoring Program Active (IMPACT) prospective five year study of Canadian children hospitalized for chickenpox or an associated complication
46. Group A streptococcal necrotizing fasciitis complicating primary varicella: A series of fourteen patients
47. Pyarthrosis of the hip complicating chickenpox
48. Life-threatening complications of varicella
49. Streptococcal osteomyelitis associated with varicella virus infection: A case report and review of the literature
50. Postvaricella suppurative meningitis: Case reports and review of the literature
51. Streptococcal toxic shock-like syndrome as a complication of varicella
52. CNS diseases associated with varicella zoster virus and herpes simplex virus infection: Pathogenesis and current therapy
53. Varicella mortality: Trends before vaccine licensure in the United States, 1970-1994
54. Varicella pneumonia in adults: A review of pulmonary manifestations, risk factors, and treatment
55. Subclinical hepatic changes in varicella infection
56. Hepatic cellular injury during varicella
57. Varicella hepatitis: A fatal case in a previously healthy immunocompetent adult
58. Reye's syndrome in the United States from 1981 through 1997
59. Mechanisms of thrombocytopenia in varicella
60. Lupus anticoagulant and protein S deficiency in otherwise healthy children with acute varicella infection
61. Postinfectious purpura fulminans caused by an autoantibody directed against protein S
62. Prevention of varicella: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
63. The nature of herpes zoster: A long-term study and a new hypothesis
64. Chronic verrucous varicella zoster virus skin lesions: Clinical, histological, molecular and therapeutic aspects
65. Varicella-zoster virus: Aspects of pathogenesis and host response to natural infection and varicella vaccine
66. Subclinical varicella-zoster virus viremia, herpes zoster and T-lymphocyte immunity to varicella-zoster virus antigens after bone marrow transplantation
67. The varicella-zoster virus: Systemic and ocular features
68. Increased incidence of herpes zoster in normal children with varicella-zoster virus during infancy: Community-based follow-up
69. Risk of AIDS after herpes zoster
70. Early vidarabine therapy to control the complication of herpes zoster in immunosuppressed patients
71. Herpes zoster and human immunodeficiency virus infection
72. Varicella-zoster infection in patients with cancer
73. Varicellazoster infection in adult cancer patients: A population study
74. Unusual features of herpes simplex or zoster infection that suggest HIV infection
75. Disseminated ecthymatous herpes varicella-zoster virus infection in patients with acquired immunodeficiency syndrome
76. Acyclovir resistant varicella zoster and HIV infection
77. Hair follicle involvement in herpes zoster: Pathway of viral spread from ganglia to skin
78. Low productive alpha-herpesviridae infection in chronic lichenoid dermatoses
79. Risk of cancer after herpes zoster: A population-based study
80. Centers for Disease Control: Classification system for human immunodeficiency virus (HIV) infection in children under 13 years of age
81. Prenatal and perinatal infections: Problems for the practicing pediatritian-group B streptococci, varicella, toxoplasmosis
82. Acyclovir for the prevention and treatment of varicella zoster in children, adolescents and pregnancy
83. Chronic verrucous varicella-zoster virus infection in patients with the acquired immunodeficiency syndrome (AIDS)
84. Acute monoarticular arthritis in association with herpes zoster
85. Esophageal stricture following esophagitis in a patient with herpes zoster: A case report
86. Herpes zoster pericarditis
87. Gastric involvement in herpes zoster
88. Zoster sine herpete
89. Populationbased study of herpes zoster and its sequelae
90. Herpes zoster: Epidemiology, clinical features, and management
91. Complications of varicella zoster virus reactivation in HIV-infected homosexual men
92. Medical complications of herpes zoster in immunocompetent patients
93. Hypotheses on the pathogenesis of herpes zoster-associated pain
94. The progression of the ocular abnormalities of herpes zoster: Histopathologic observations of nine cases
95. The ocular manifestations of herpes zoster, varicella, infectious mononucleosis, and cytomegalovirus diseases
96. Association of varicella zoster dermatitis with acute retinal necrosis syndrome
97. Necrotizing fasciitis complicating disseminated cutaneous herpes zoster
98. Skin disorders in black children
99. Granuloma annulare in herpes zoster scars
100. Leukocytoclastic vasculitis associated with cutaneous infection by herpesvirus
101. Fatal varicella in an immunocompromised adult
102. The Tzanck Smear: Old, but still of inestimable value
103. Routine detection of herpes simplex virus and varicella zoster virus by polymerase chain reaction reveals that initial herpes zoster is frequently misdiagnosed as herpes simplex
104. Investigation of vesicular rashes for HSV and VZV by PCR
105. Aspirin and Reye syndrome
106. A controlled trial of acyclovir for chickenpox in normal children
107. Treatment of adult varicella with oral acyclovir: A randomized, placebo-controlled trial
108. The treatment of varicella in otherwise healthy adolescents
109. The use of oral acyclovir in otherwise healthy children with varicella
110. Intravenous acyclovir therapy for varicella in immunocompromised children
111. Acyclovir prevents dissemination of varicella in immunocompromised children
112. Acyclovir therapy of chickenpox in immunosuppressed children: A collaborative study
113. Valacyclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults
114. Famciclovir herpes zoster clinical study group: Famciclovir, a new oral anti-herpes drugresults of the first controlled clinical study demonstrating its efficacy and safety in the treatment of uncomplicated herpes zoster in immunocompetent patients
115. Famciclovir for the treatment of acute herpes zoster: Effects on acute disease and postherpetic neuralgia-a randomized, double-blind, placebo-controlled trial
116. Treatment of acute herpes zoster: Effect on early (< 48 h) versus late (48-72 h) therapy with acyclovir and valaciclovir on prolonged pain
117. Postherpetic neuralgia: Pathogenesis, treatment, and prevention
118. Treatment of varicella-zoster virus and postherpetic neuralgia
119. A randomized trial of acyclovir for 7 days or 21 days with and without prednisolone for treatment of acute herpes zoster
120. Acyclovir with and without prednisone for the treatment of herpes zoster: A randomized, placebo-controlled trial
121. Treatment of Ramsay Hunt syndrome with acyclovir-prednisone: Significance of early diagnosis and treatment
122. Antidepressants and anticonvulsants for diabetic neuropathy and postherpetic neuralgia: A quantitative systematic review
123. Treatment of postherpetic trigeminal neuralgia with the gamma knife
124. Acyclovir-resistant varicella zoster virus infection after chronic and acyclovir therapy in patients with acquired immunodeficiency virus (AIDS)
125. Novel agents for the therapy of varicella-zoster virus infections
126. Cost-effectiveness of a routine varicella vaccination program for US children
127. Prevention of varicella: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
128. Varicella and zoster in children after kidney transplantation: Longterm results of vaccination
129. The incidence of zoster after immunization with live attenuated varicella vaccine
130. Immunization of healthy adults with live attenuated varicella vaccine
131. Varicella vaccine (VARIVAX) in healthy children and adolescents: Results from clinical trials, 1987 to 1989
132. Clinical trials of varicella vaccine in healthy children
133. Efficacy, immunogenicity, safety, and use of live attenuated chickenpox vaccine
134. Viral strain identification in varicella vaccinees with disseminated rashes
135. Risk factors for breakthrough varicella in healthy children
136. Modified chickenpox in children immunized with the Oka/Merck varicella vaccine
137. Immune senescence
138. Lasting immunity to varicella in doctors study (L.I.V.I.D. study)
139. Comparison of a live attenuated and an inactivated varicella vaccine to boost the varicella-specific immune response in seropositive people 55 years of age and older
140. Immunology of varicella immunization in the elderly
141. Live vaccine used to prevent the spread of varicella in children in hospital
142. Postexposure varicella vaccination in siblings of children with active varicella